Guest: Gregory S. Sayuk, MD, MPH

Please click here for full Prescribing Information.

Irritable bowel syndrome with diarrhea can have a significant impact on patients’ daily activities due to debilitating symptoms like abdominal pain and diarrhea, both of which could be a result of alterations in the gut microbiota. Joining us to discuss XIFAXAN (rifaximin), the only FDA-approved treatment that alters the gut microbiota in IBS-D, is Dr. Gregory Sayuk.